According to IMARC Group's latest research report, titled "๐๐๐ญ๐ข๐ฏ๐ ๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐ง๐ ๐ซ๐๐๐ข๐๐ง๐ญ๐ฌ (๐๐๐) ๐๐๐ซ๐ค๐๐ญ: ๐๐ฅ๐จ๐๐๐ฅ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ซ๐๐ง๐๐ฌ, ๐๐ก๐๐ซ๐, ๐๐ข๐ณ๐, ๐๐ซ๐จ๐ฐ๐ญ๐ก, ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ, ๐๐ง๐ ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐-๐๐๐๐," offers a comprehensive analysis of the industry, which comprises insights on the active pharmaceutical ingredients (API) market share. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global active pharmaceutical ingredients (API) market size reached ๐๐$ ๐๐๐.๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐. Looking forward, IMARC Group expects the market to reach ๐๐$ ๐๐๐.๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, exhibiting a ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐ซ๐๐ญ๐ (๐๐๐๐) ๐จ๐ ๐.๐% during 2023-2028.
๐๐๐ญ๐ข๐ฏ๐ ๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐ง๐ ๐ซ๐๐๐ข๐๐ง๐ญ๐ฌ (๐๐๐) ๐๐๐ซ๐ค๐๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ:
Active pharmaceutical ingredients (API) are chemical compounds obtained from various sources, including plants, animals, and synthetic processes. They are synthetic active components of a finished pharmaceutical product (FPP) used to produce intended pharmacological outcomes. They are the substance in medications that are responsible for treating the illness or condition it is intended to treat. They are utilized in different medications, including prescription drugs, over-the-counter (OTC) medications, and dietary supplements.
๐๐๐ญ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ญ -https://www.imarcgroup.com/active-pharmaceutical-ingredients-market/requestsample
๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ญ๐ข๐ฏ๐ ๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐ง๐ ๐ซ๐๐๐ข๐๐ง๐ญ๐ฌ (๐๐๐) ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฆ๐๐ง๐ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ:
The increasing prevalence of chronic diseases, cancer, arthritis, and respiratory disorders and the rising aging population, which is more prone to develop these medical conditions, represents one of the key factors driving the demand for APIs around the world. Moreover, the growing need for generic drugs on account of expanding healthcare costs is catalyzing the demand for APIs to improve the effectiveness of drugs. In addition, the increasing preference for personalized medicines and rising demand for biologic drugs that are made using living cells is favoring the market growth. Apart from this, regulatory authorities of numerous countries are implementing strict regulations to ensure the safety and quality of excipients used in the production of medicinal products. Furthermore, extensive research and development (R&D) activities in the pharmaceutical industry by key players to develop next-generation medicines and therapies are influencing the market positively.
๐๐จ ๐ฒ๐จ๐ฎ ๐ค๐ง๐จ๐ฐ ๐ฆ๐จ๐ซ๐ ๐ข๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง, ๐๐จ๐ง๐ญ๐๐๐ญ ๐ญ๐จ ๐จ๐ฎ๐ซ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ญ ๐๐ญ- https://www.imarcgroup.com/active-pharmaceutical-ingredients-market
๐๐จ๐ฉ ๐๐๐ญ๐ข๐ฏ๐ ๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐ง๐ ๐ซ๐๐๐ข๐๐ง๐ญ๐ฌ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐จ๐ซ๐ฅ๐๐ฐ๐ข๐๐:
- Pfizer Inc.
- Novartis International AG
- Sanofi SA
- Boehringer Ingelheim Group
- Bristol-Myers Squibb Company
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly and Company
- GlaxoSmithKline plc
- Merck & Co. Inc.
- AbbVie Inc.
๐๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ซ๐ฎ๐ ๐๐ฒ๐ฉ๐:
- Innovative Active Pharmaceutical Ingredients (API)
- Generic Active Pharmaceutical Ingredients (API)
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐๐ง๐ฎ๐๐๐๐ญ๐ฎ๐ซ๐๐ซ:
- Captive Manufacturers
- Merchant API Manufacturers
- Innovative Merchant API Manufacturers
- Generic Merchant API Manufacturers
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ฒ๐ง๐ญ๐ก๐๐ฌ๐ข๐ฌ:
(๐). ๐๐ฒ๐ง๐ญ๐ก๐๐ญ๐ข๐ ๐๐๐ญ๐ข๐ฏ๐ ๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐ง๐ ๐ซ๐๐๐ข๐๐ง๐ญ๐ฌ (๐๐๐):
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ฒ๐ฉ๐:
- Innovative Synthetic APIs
- Generic Synthetic APIs
(๐). ๐๐ข๐จ๐ญ๐๐๐ก ๐๐๐ญ๐ข๐ฏ๐ ๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐ง๐ ๐ซ๐๐๐ข๐๐ง๐ญ๐ฌ (๐๐๐):
(๐). ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ฒ๐ฉ๐:
- Innovative Biotech APIs
- Biosimilars
(๐). ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐๐ญ:
- Monoclonal Antibodies
- Vaccines
- Cytokines
- Fusion Proteins
- Therapeutic Enzymes
- Blood Factors
(๐). ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ฑ๐ฉ๐ซ๐๐ฌ๐ฌ๐ข๐จ๐ง ๐๐ฒ๐ฌ๐ญ๐๐ฆ:
- Mammalian Expression Systems
- Microbial Expression Systems
- Yeast Expression Systems
- Transgenic Animal Systems
- Others
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐ ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง:
- Oncology
- Cardiovascular and Respiratory
- Diabetes
- Central Nervous System Disorders
- Neurological Disorders
- Others
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐๐ ๐ข๐จ๐ง:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
๐๐ก๐จ ๐ฐ๐ ๐๐ซ๐:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
๐๐จ๐ง๐ญ๐๐๐ญ ๐ฎ๐ฌ:
๐๐๐๐๐ ๐๐ซ๐จ๐ฎ๐ฉ
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800